ArticleOncology letters2024

Lenvatinib‑based treatment regimens in conversion therapy of unresectable hepatocellular carcinoma: A systematic review and meta‑analysis.

Saixin Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.